A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Islam, Saidul |
---|---|
Outros Autores: | Sharmin, Shahana |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2022
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/17308 |
Registos relacionados
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Por: Karim, Azrin
Publicado em: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Por: Meem, Manila
Publicado em: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Por: Alam, Tahera
Publicado em: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
Por: Jahan, Nusrat
Publicado em: (2024)